EXCLUSIVE: Eli Lilly gave compassionate use access to retatrutide, their unapproved powerful obesity drug, to a 79-year-old man in April. The application was ... (opens in new tab)

EXCLUSIVE: Eli Lilly gave compassionate use access to retatrutide, their unapproved powerful obesity drug, to a 79-year-old man in April. The application was arranged by a top doctor at NIH, and cleared by the FDA. <a class="entity-url" data-preview="true" href=" told STAT that application drew interest from top health officials. Given the demographics and the peculiar nature of the application, I asked the WH if this patient was President Trump, who turned 80 a week ago. I did not get a dire...